Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Dicerna Pharmaceuticals Inc (DRNA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2022 |
SC 13G/A
| BALYASNY ASSET MANAGEMENT LLC reports a 0% stake in Dicerna Pharmaceuticals Inc. |
| 01/10/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 01/03/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/03/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/03/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/03/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/29/2021 |
4
| Koppel Adam (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Unknown transaction of 3,080,237 shares
@ $38.25, valued at
$117.8M
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 25,000 options to buy
@ $3.47, valued at
$86.8k
Disposed/sold 25,000 options to buy
@ $13.08, valued at
$327k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Zeng Ling (Chief Legal Officer & Sec'y) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 5,032 shares
@ $38.25, valued at
$192.5k
Disposed/sold 7,688 restricted stock units
@ $0
Disposed/sold 13,669 restricted stock units
@ $0
Disposed/sold 81,825 options to buy
@ $18.69, valued at
$1.5M
Disposed/sold 46,120 options to buy
@ $24.05, valued at
$1.1M
|
|
| 12/29/2021 |
4
| Weissman James B (COO & EVP) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 18,100 shares
@ $38.25, valued at
$692.3k
Disposed/sold 25,950 restricted stock units
@ $0
Disposed/sold 11,325 restricted stock units
@ $0
Disposed/sold 11,879 options to buy
@ $2.97, valued at
$35.3k
Disposed/sold 33,999 options to buy
@ $9.09, valued at
$309.1k
Disposed/sold 105,000 options to buy
@ $9.3, valued at
$976.5k
Disposed/sold 180,000 options to buy
@ $11.77, valued at
$2.1M
Disposed/sold 111,800 options to buy
@ $16.3, valued at
$1.8M
Disposed/sold 75,000 options to buy
@ $18.5, valued at
$1.4M
Disposed/sold 121,300 options to buy
@ $22.58, valued at
$2.7M
Disposed/sold 68,100 options to buy
@ $24.05, valued at
$1.6M
|
|
| 12/29/2021 |
4
| Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $14.76, valued at
$369k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Pagan Douglas W. (CFO) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 7,775 shares
@ $38.25, valued at
$297.4k
Disposed/sold 20,475 restricted stock units
@ $0
Disposed/sold 6,150 restricted stock units
@ $0
Disposed/sold 95,650 options to buy
@ $20.79, valued at
$2M
Disposed/sold 36,900 options to buy
@ $24.05, valued at
$887.4k
|
|
| 12/29/2021 |
4
| KOZIN MARC D (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Disposed/sold 6,333 shares
@ $38.25, valued at
$242.2k
Disposed/sold 5,000 shares
@ $38.25, valued at
$191.3k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $10.31, valued at
$257.8k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| HOFFMAN STEPHEN J (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 16,157 shares
@ $38.25, valued at
$618k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 15,000 options to buy
@ $3.26, valued at
$48.9k
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 25,000 options to buy
@ $13.08, valued at
$327k
Disposed/sold 15,000 options to buy
@ $13.87, valued at
$208.1k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 25,000 options to buy
@ $16.3, valued at
$407.5k
Disposed/sold 15,000 options to buy
@ $18.73, valued at
$281k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| GRAY PATRICK M. (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $14.32, valued at
$358k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Freed Martin I (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $3.26, valued at
$81.5k
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 25,000 options to buy
@ $13.08, valued at
$327k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| FAMBROUGH DOUGLAS (CEO) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Disposed/sold 231,431 shares
@ $38.25, valued at
$8.9M
Disposed/sold 59,850 restricted stock units
@ $0
Disposed/sold 41,250 restricted stock units
@ $0
Disposed/sold 191,330 options to buy
@ $2.97, valued at
$568.3k
Disposed/sold 281,250 options to buy
@ $3.42, valued at
$961.9k
Disposed/sold 55,055 options to buy
@ $3.42, valued at
$188.3k
Disposed/sold 225,000 options to buy
@ $9.09, valued at
$2M
Disposed/sold 255,000 options to buy
@ $9.3, valued at
$2.4M
Disposed/sold 505,000 options to buy
@ $11.77, valued at
$5.9M
Disposed/sold 71,900 options to buy
@ $16.3, valued at
$1.2M
Disposed/sold 200,000 options to buy
@ $16.3, valued at
$3.3M
|
|
| 12/29/2021 |
4
| Doberstein Stephen K (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $15.61, valued at
$390.3k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Ciappenelli Robert D. (Chief Strategy Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 14,813 shares
@ $38.25, valued at
$566.6k
Disposed/sold 10,275 restricted stock units
@ $0
Disposed/sold 17,325 restricted stock units
@ $0
Disposed/sold 270,000 options to buy
@ $15.61, valued at
$4.2M
Disposed/sold 76,144 options to buy
@ $22.58, valued at
$1.7M
Disposed/sold 61,500 options to buy
@ $24.05, valued at
$1.5M
|
|
| 12/29/2021 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 4,666 shares
@ $38.25, valued at
$178.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 8,000 options to buy
@ $14.13, valued at
$113k
Disposed/sold 25,000 options to buy
@ $14.76, valued at
$369k
Disposed/sold 33,000 options to buy
@ $15.44, valued at
$509.5k
Disposed/sold 21,000 options to buy
@ $21.61, valued at
$453.8k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Brown Bob D (Chief Scientific Ofr., EVP R&D) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 2,367 shares
@ $38.25, valued at
$90.5k
Disposed/sold 25,950 restricted stock units
@ $0
Disposed/sold 11,325 restricted stock units
@ $0
Disposed/sold 85,000 options to buy
@ $9.09, valued at
$772.7k
Disposed/sold 105,000 options to buy
@ $9.3, valued at
$976.5k
Disposed/sold 180,000 options to buy
@ $11.77, valued at
$2.1M
Disposed/sold 165,050 options to buy
@ $16.3, valued at
$2.7M
Disposed/sold 75,000 options to buy
@ $18.5, valued at
$1.4M
Disposed/sold 121,300 options to buy
@ $22.58, valued at
$2.7M
Disposed/sold 68,100 options to buy
@ $24.05, valued at
$1.6M
|
|
| 12/29/2021 |
4
| Aradhye Shreeram (EVP & Chief Medical Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 6,973 shares
@ $38.25, valued at
$266.7k
Disposed/sold 21,075 restricted stock units
@ $0
Disposed/sold 8,513 restricted stock units
@ $0
Disposed/sold 124,700 options to buy
@ $18.69, valued at
$2.3M
Disposed/sold 51,070 options to buy
@ $24.05, valued at
$1.2M
|
|
| 12/28/2021 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 12/28/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/28/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/28/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/28/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/28/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/28/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/28/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/28/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/28/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/28/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/28/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 12/28/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|